Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

MK-0518 active, well tolerated in resistant HIV-1 infection

Feb. 15, 2006

DEBIO-025 well tolerated in HIV-1 infected subjects

Feb. 15, 2006

New selective nonpeptide CCR8 agonist presented

Feb. 14, 2006

Avexa signs license agreement with MNLpharma for HIV integrase inhibitors

Feb. 14, 2006

Medivir designates candidate drug from HIV NNRTI program

Feb. 13, 2006

Fortovase discontinued, Invirase preferred option

Feb. 9, 2006

CSA-54 shows potent virucidal activity in in vitro tests against HIV

Feb. 8, 2006

CONRAD and Cellegy sign agreement for microbicide R&D

Feb. 3, 2006

Benitec delays IND filing for HIV/AIDS therapeutic

Feb. 2, 2006

Pharmexa begins phase I study for HIV vaccine candidates

Jan. 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...